Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis : A Case Report
Joint Authors
Ferri, Clodoveo
Sebastiani, Marco
Colaci, Michele
Meacci, Marisa
Sandri, Gilda
Source
Case Reports in Infectious Diseases
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-06-30
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations.
We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.
American Psychological Association (APA)
Colaci, Michele& Sebastiani, Marco& Sandri, Gilda& Meacci, Marisa& Ferri, Clodoveo. 2011. Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis : A Case Report. Case Reports in Infectious Diseases،Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-479098
Modern Language Association (MLA)
Colaci, Michele…[et al.]. Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis : A Case Report. Case Reports in Infectious Diseases No. 2011 (2011), pp.1-3.
https://search.emarefa.net/detail/BIM-479098
American Medical Association (AMA)
Colaci, Michele& Sebastiani, Marco& Sandri, Gilda& Meacci, Marisa& Ferri, Clodoveo. Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis : A Case Report. Case Reports in Infectious Diseases. 2011. Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-479098
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-479098
